ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 373

Menopause Occurs Earlier and Is An Independent Risk Factor For Osteoporosis In Women With Rheumatoid Arthritis

Michael Cocker1, Alexander Oldroyd2 and Marwan Bukhari3, 1Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom, 2Lancaster Medical School, Lancaster University, Lancaster, United Kingdom, 3Department of Rheumatology, Royal Lancaster Infirmary, Lancaster, United Kingdom

Meeting: 2013 ACR/ARHP Annual Meeting

Keywords: Bone density, menopause, Osteoporosis and rheumatoid arthritis (RA), Reproductive Health

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Title: Rheumatoid Arthritis - Clinical Aspects I: Comorbidities in Rheumatoid Arthritis

Session Type: Abstract Submissions (ACR)

Background/Purpose:

Rheumatoid arthritis (RA) and early menopause (<45 years) are recognised risk factors for the development of osteoporosis and form part of the World Health Organisation “FRAX” 10-year fracture risk-stratification tool[1]. It is not known whether age of menopause is an independent risk factor for osteoporosis in women with RA. Evidence exists linking connective tissue diseases to earlier menopause[2]however whether this also occurs in RA is unknown.

This paper aims to establish whether RA is associated with earlier menopause and whether age of menopause is an independent risk factor for osteoporosis in RA.

Methods:

Data from female patients with RA attending for dual-energy X-ray absorptiometry (DXA) assessment between 2004 and 2011 was analysed using a nested case-control approach. Control subjects with no pre-defined indication for DEXA assessment were age-matched with RA subjects. Osteoporosis was defined as any hip or lumbar spine (L1-L4) T-score <-2.5.  Student’s t-test was used to compare age of menopause in the RA and control group. Subjects were divided into 3 tertiles according to age of menopause and logistic regression performed to assess for relationships with osteoporosis. All statistical analysis was performed using STATA v11.2, with results expressed as odds ratios (OR) with 95% confidence intervals (95%CI). P values <0.05 were considered significant.

Results:

397 subjects (median age 69.5 years, interquartile range 62.1,76.5) were matched for age with 397 controls. Mean age of menopause was lower in RA subjects (48.1 years vs. 49.7 years, mean difference 1.6 years) and was significant (p<0.001). After adjusting for age the earliest menopause tertile (median age of menopause 43.9 years) was associated with the highest odds of osteoporosis (OR 1.65 95%CI 1.13,2.41 p=0.01). Odds were increased to a lesser degree in the second-earliest tertile (median menopause age 50.2 years, OR 1.48 95%CI 1.00,2.17 p=0.048). No such associations were seen in controls.

Conclusion:

This case-control study has demonstrated for the first time that women with RA experience the menopause earlier, and that earlier age of menopause is an independent risk factor for the development of osteoporosis in this population.

References:

  1. FRAX tool: http://www.shef.ac.uk/FRAX/index.aspx
  2. Ekblom-Kullberg S. et al “Reproductive health in women with systemic lupus erythematosus compared to population controls.” Scandinavian Journal of Rheumatology. 2009;38(5): 375-380

Disclosure:

M. Cocker,
None;

A. Oldroyd,
None;

M. Bukhari,
None.

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2013 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/menopause-occurs-earlier-and-is-an-independent-risk-factor-for-osteoporosis-in-women-with-rheumatoid-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology